Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution.

Tomisaki I, Ikuta H, Higashijima K, Onishi R, Minato A, Fujimoto N.

Cancer Invest. 2019;37(10):524-530. doi: 10.1080/07357907.2019.1675076. Epub 2019 Oct 10.

PMID:
31597501
2.

Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.

Suardi N, Larcher A, Haese A, Ficarra V, Govorov A, Buffi NM, Walz J, Rocco B, Borghesi M, Steuber T, Pini G, Briganti A, Mottrie AM, Guazzoni G, Montorsi F, Pushkar D, Van Der Poel H; EAU Young Academic Urologists–Robotic Section.

Eur Urol. 2014 Oct;66(4):635-43. doi: 10.1016/j.eururo.2013.12.059. Epub 2014 Jan 4.

PMID:
24411992
3.

Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.

Preisser F, Bandini M, Marchioni M, Nazzani S, Tian Z, Pompe RS, Fossati N, Briganti A, Saad F, Shariat SF, Heinzer H, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Prostate. 2018 May;78(6):469-475. doi: 10.1002/pros.23491. Epub 2018 Feb 19.

PMID:
29460290
4.

Radical Prostatectomy and Pelvic Lymph Node Dissection in Kaiser Permanente Southern California: 15-Year Experience.

Banapour P, Schumacher A, Lin JC, Finley DS.

Perm J. 2019;23. pii: 17-233. doi: 10.7812/TPP/17-233.

5.

The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.

Fossati N, Willemse PM, Van den Broeck T, van den Bergh RCN, Yuan CY, Briers E, Bellmunt J, Bolla M, Cornford P, De Santis M, MacPepple E, Henry AM, Mason MD, Matveev VB, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Lam TB, Mottet N, Joniau S.

Eur Urol. 2017 Jul;72(1):84-109. doi: 10.1016/j.eururo.2016.12.003. Epub 2017 Jan 24. Review.

6.

Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?

Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J.

Investig Clin Urol. 2018 Mar;59(2):83-90. doi: 10.4111/icu.2018.59.2.83. Epub 2018 Feb 22.

7.

The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Narita T, Koie T, Ookubo T, Mitsuzuka K, Narita S, Yamamoto H, Inoue T, Hatakeyama S, Kawamura S, Tochigi T, Habuchi T, Arai Y, Ohyama C.

Med Oncol. 2017 Jan;34(1):1. Epub 2016 Nov 26.

PMID:
27889880
8.

Pelvic lymph node dissection in prostate cancer.

Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE.

Eur Urol. 2009 Jun;55(6):1251-65. doi: 10.1016/j.eururo.2009.03.012. Epub 2009 Mar 10. Review.

PMID:
19297079
9.
10.

Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy?

Daimon T, Miyajima A, Maeda T, Hattori S, Yasumizu Y, Hasegawa M, Kosaka T, Kikuchi E, Nakagawa K, Oya M.

J Endourol. 2012 Sep;26(9):1199-202. doi: 10.1089/end.2011.0589. Epub 2012 Jun 25.

PMID:
22524402
11.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.

Yaxley JW, Dagher J, Delahunt B, Egevad L, Srigley J, Samaratunga H.

World J Urol. 2018 Jan;36(1):15-20. doi: 10.1007/s00345-017-2119-0. Epub 2017 Nov 7.

PMID:
29116393
12.

Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer.

Mandel P, Kriegmair MC, Bogdan K, Boehm K, Budäus L, Graefen M, Huland H, Tilki D.

Eur Urol Focus. 2017 Apr;3(2-3):248-255. doi: 10.1016/j.euf.2016.02.018. Epub 2016 Apr 20.

PMID:
28753755
13.

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.

Dorin RP, Lieskovsky G, Fairey AS, Cai J, Daneshmand S.

Urol Oncol. 2013 Nov;31(8):1441-7. doi: 10.1016/j.urolonc.2012.03.006. Epub 2012 Apr 18.

PMID:
22516714
14.

Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.

Altok M, Babaian K, Achim MF, Achim GC, Troncoso P, Matin SF, Chapin BF, Davis JW.

BJU Int. 2018 Jul;122(1):66-75. doi: 10.1111/bju.14164. Epub 2018 Mar 25.

15.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

16.

Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.

Sengupta S, Weerakoon M, Sethi K, Ischia J, Webb DR.

BJU Int. 2012 Apr;109 Suppl 3:48-51. doi: 10.1111/j.1464-410X.2012.11047.x.

18.

Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.

Liss MA, Palazzi K, Stroup SP, Jabaji R, Raheem OA, Kane CJ.

World J Urol. 2013 Jun;31(3):481-8. doi: 10.1007/s00345-013-1056-9. Epub 2013 Mar 20.

PMID:
23512231
19.

Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.

Heidenreich A, Ohlmann CH, Polyakov S.

Eur Urol. 2007 Jul;52(1):29-37. Epub 2007 Apr 11. Review.

PMID:
17448592
20.

Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.

Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Sun M, Karakiewicz PI, Seitz C, Schramek P, Herman MP, Becker A, Loidl W, Pummer K, Nonis A, Lee RK, Lotan Y, Scherr DS, Seiler D, Chun FK, Graefen M, Tewari A, Gönen M, Montorsi F, Shariat SF, Briganti A.

Eur Urol. 2014 Sep;66(3):439-46. doi: 10.1016/j.eururo.2013.06.041. Epub 2013 Jul 2.

PMID:
23850255

Supplemental Content

Support Center